Does Tudorza (tudorza pressair/aclidinium) treat COPD or just asthma?
Tudorza (aclidinium) is used as a long-term maintenance inhaler for chronic obstructive pulmonary disease (COPD), aiming to improve breathing and reduce symptoms. It is not a rescue (quick-relief) medicine for sudden breathing problems.
How does Tudorza help COPD symptoms?
Tudorza is an inhaled anticholinergic (a long-acting muscarinic antagonist, or LAMA). By blocking muscarinic receptors in the airways, it helps relax airway muscles and can reduce bronchoconstriction, which may make it easier to breathe over time.
Can Tudorza be used if I have COPD with frequent exacerbations?
Tudorza is generally used to manage COPD symptoms as part of long-term treatment. For people with frequent exacerbations, clinicians often combine or step up maintenance inhalers based on symptom level and exacerbation history, but Tudorza’s specific role depends on the person’s overall regimen.
Is Tudorza the same as rescue inhalers for COPD?
No. Rescue inhalers (like short-acting bronchodilators) are for sudden symptom relief. Tudorza is a maintenance inhaler intended for ongoing control, not for acute attacks.
What side effects do COPD patients ask about with Tudorza?
Common concerns with inhaled anticholinergics include dry mouth, throat irritation, and sometimes difficulty urinating, depending on the person. If you have glaucoma (especially narrow-angle) or urinary retention issues, you should ask a clinician whether Tudorza is appropriate.
Who makes Tudorza, and where can I check IP/patent details?
For manufacturer and patent/exclusivity tracking, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search “Tudorza/aclidinium” on the site).